PPI network analyses demonstrated that ZNF217, a transcription factor suggested as a prognostic marker and therapeutic target in other types of cancer32–35, is a key hub protein in LD-type ICC. The gene discussed is ZNF217; the disease is intrahepatic cholangiocarcinoma.